CD4 and cancer: The available vaccine platforms are illustrated in Figure 1B. DNA and RNA vaccines encoding selected tumour antigens or synthetic long peptides (SLPs) vaccines co-delivering CD4 and CD8 epitopes have recently been highlighted as optimal cancer vaccine modalities (97).